TigerOak Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.09M Buy
4,182
+150
+4% +$38.5K 0.29% 51
2026
Q2
$1.01M Buy
4,032
+70
+2% +$15.1K 0.29% 55
2026
Q1
$862K Buy
3,962
+7
+0.2% +$1.55K 0.27% 50
2025
Q4
$904K Hold
3,955
– – 0.28% 52
2025
Q3
$916K Hold
3,955
– – 0.28% 51
2025
Q2
$734K Hold
3,955
– – 0.25% 58
2025
Q1
$829K Hold
3,955
– – 0.32% 48
2024
Q4
$703K Hold
3,955
– – 0.26% 55

Other funds holding ABBV

TigerOak Management's ABBV Position: Q3 2026 in Review

TigerOak Management increased its AbbVie (ABBV) stake by 3.7% in Q3 2026, buying an estimated $38.5K and bringing the position to 4,182 shares worth $1.09M. The position accounts for 0.29% of the portfolio, ranked #51.

TigerOak Management first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • TigerOak Management held 4,182 shares of AbbVie worth $1.09M as of Q3 2026.
  • TigerOak Management bought 150 AbbVie shares in Q3 2026, an estimated $38.5K.
  • AbbVie made up 0.29% of TigerOak Management's portfolio in Q3 2026, its #51 holding.
  • TigerOak Management first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on TigerOak Management's 13F filing for Q3 2026, filed 23 Oct 2026.